Johnson & Johnson Raises Full-Year Earnings Guidance After Q3 Beat
Johnson & Johnson reported third-quarter adjusted earnings of $2.59 per share, above expectations, and raised its full-year outlook. Medical technology business stumbles left investors lukewarm.